Reports for APOTEX INC

Formerly known as AA PHARMA INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

26 (7%)

Discontinued:

343 (93%)

Reversed:

0 (0%)

369

145 (4%)

73 (30%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROMORPHONE 1MG TABLET Resolved 2017-08-23 2017-09-01 20105
APO-HYDROMORPHONE 1MG TABLET Resolved 2017-10-11 2018-01-22 25214
APO-HYDROMORPHONE 4MG TABLET Resolved 2021-07-16 2021-07-24 142683
APO-HYDROMORPHONE 8MG TABLET Resolved 2021-01-08 2021-03-01 131163
APO-HYDROMORPHONE 2MG TABLET Resolved 2020-04-07 2020-05-22 111224
APO-HYDROMORPHONE 8MG TABLET Resolved 2017-07-31 2017-09-06 17605
APO-HYDROMORPHONE 2MG TABLET Resolved 2017-10-17 2017-12-15 26163
APO-HYDROMORPHONE 8MG TABLET Resolved 2021-06-18 2021-07-21 141241
APO-HYDROMORPHONE 8MG TABLET Resolved 2023-06-09 2023-10-15 194587
APO-HYDROMORPHONE 4MG TABLET Resolved 2017-11-02 2017-12-31 27809
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Resolved 2019-01-03 2020-04-04 71127
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Resolved 2019-01-03 2020-04-04 71124
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77855
APO-HYDROMORPHONE CR 4.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-11-13 2020-04-04 98562
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Resolved 2019-01-30 2020-04-04 74019
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-20 2020-04-04 79039
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77849
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77858
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77852
APO-HYDROXYQUINE 200MG TABLET Resolved 2024-05-24 2024-06-14 228780
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE 25MG TABLET Discontinued 2020-07-10 2020-07-10 119950
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RILUZOLE 50MG TABLET To be discontinued 2025-12-02 2025-12-02 257819
APO-RILUZOLE 50MG TABLET To be discontinued 2018-09-08 2018-09-08 60744
APO-RISEDRONATE 35MG TABLET Discontinued 2018-09-08 2018-09-15 60747
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965